natgillin/translations-raw huggingface dataset:
The medicine is available as tablets (50 mg) and the recommended dose is two tablets twice a day taken together with food.
Ovaj je lijek dostupan u obliku tableta (50 mg), a preporučena doza su dvije tablete dvaput dnevno uzete uz obrok.
the medicine is cloudy
ako je lijek mutan
the medicine is cloudy
je lijek mutan
the medicine is cloudy or hazy;
je lijek zamućen ili neproziran;
The medicine is cloudy or there are particles in it.
Ukoliko lijek izgleda mutan ili su u njemu vidljive čestice.
The medicine is cloudy, is distinctly brown, or has small particles.
Lijek je mutan, izrazito smeđe boje ili sadrži male čestice.
The medicine is given in two equally divided doses - once in the morning and once in the evening at about the same time each day.
Lijek se primjenjuje podijeljen na dvije jednake doze – jedna se primjenjuje ujutro, a druga navečer, svakoga dana u približno isto vrijeme.
The medicine is given into a vein by slow injection usually lasting around one minute.
Lijek se primjenjuje intravenozno sporom injekcijom koja najčešće traje otprilike jednu minutu.
The medicine is injected under your skin and can be given by yourself or someone else (caregiver).
Lijek se injicira pod kožu, a možete ga primijeniti samostalno ili Vam ga može injicirati netko drugi (skrbnik).
The medicine is not authorised for use in horses producing milk for human consumption.
VMP nije odobren za primjenu u konja od kojih se dobiva mlijeko za ljudsku prehranu.
The medicine is stable in the pump for 45 days at 37°C.
Lijek u pumpi stabilan je tijekom 45 dana na temperaturi od 37°C.
The medicine is taken by mouth mixed in liquid or semi-solid food.
Lijek se uzima kroz usta pomješan u tekućinu ili polukrutu hranu.
The medicine is to be given during or straight after a feed.
Lijek se treba dati tijekom ili odmah nakon hranjenja.
The medicine is used in patients who have a normal heart rhythm but whose heart rate is at least 70 beats per minute.
Lijek se koristi u bolesnika koji imaju i normalni srčani ritam, no čija frekvencija srca iznosi najmanje 70 otkucaja u minuti.
The medicine is used in two different situations:
Lijek se koristi u dvije različite situacije:
The medicine is used together with another hormone called Follicle Stimulating Hormone, (FSH), to bring about the development of follicles, which are in the ovary, the structures maturing the eggs (ova).
Ovaj lijek se koristi skupa s drugim hormonom zvanim hormonom stimulacije folikula (FSH) kako bi se razvili folikuli koji su u jajnicima, a sazrijevaju do jajnih stanica.
The medicine may be taken with or without food.
Lijek se može uzeti s hranom ili bez nje.
The medicine may be taken with or without food.
Lijek se može uzimati s hranom ili bez nje.
The medicine may not be tasted or felt, even when using the inhaler correctly.
Možda nećete moći okusiti ni osjetiti lijek, čak ni kada inhalator koristite na pravilan način.
The medicine must also not be used in patients with conditions putting them at risk of major bleeding, such as an ulcer in the gut, or in patients being treated with other anticoagulant medicines except in specific circumstances (see summary of product characteristics).
Lijek se ne smije koristiti u bolesnika sa stanjem koje ih izlaže riziku od masovnog krvarenja, poput čira u crijevima ili u bolesnika koji se liječe drugim antikoagulantima izuzev u specifičnim okolnostima (vidjeti sažetak opisa svojstava lijeka).
The medicine must be diluted before it is given.
Lijek se prije primjene mora razrijediti.
The medicine must be infused slowly at first.
Lijek se u početku daje slabijim intenzitetom.
The medicine must be used immediately after opening or dilution.
Nakon otvaranja ili razrjeđivanja lijek se mora odmah primijeniti.
The medicine must not be frozen.
Lijek ne smijete zamrzavati.
The medicine must not be used in patients who have or are suspected to have an infection of the eye or the tissues around the eye.
Lijek se ne smije koristiti u bolesnika koji imaju ili za koje se sumnja da imaju upalu oka ili tkiva oko oka.
The medicine packs containing Imnovid capsules will carry a warning on the risk of severe birth defects.
Pakiranje kapsula lijeka Imnovid nosit će oznaku upozorenja o riziku o teškim prirođenim malformacijama nerođene djece.
The medicine should be clear or slightly opalescent, colourless or pale yellow, and may contain small white or almost transparent particles of protein.
Otopina treba bi biti bistra ili blago opalescentna, bezbojna ili svijetložuta i može sadržavati male bijele ili gotovo prozirne čestice proteina.
The medicine should be clear or slightly opalescent, colourless or pale yellow, and may contain small white or almost transparent particles of protein.
Otopina treba biti bistra ili blago opalescentna, bezbojna ili svijetložuta i može sadržavati male bijele ili gotovo prozirne čestice proteina.
The medicine should be injected slowly at different places on the abdomen every day.
Lijek je potrebno svakodnevno polako injektirati na različitim mjestima na abdomenu.
The medicine should be injected when the first sign of bleeding occurs
Lijek treba injicirati kada se pojavi prvi znak krvarenja.
The medicine should be injected within 5 minutes after the cap has been removed.
Lijek morate ubrizgati u roku od 5 minuta nakon skidanja poklopca.
The medicine should be introduced into the tube leaving the body (arterial line) at the start of the dialysis session.
Lijek je potrebno na početku postupka dijalize ubrizgati u cijev kojom krv izlazi iz tijela (arterijska linija).
The medicine should not be used for more than 28 days after it has been mixed.
Lijek se ne smije koristiti ako je prošlo više od 28 dana nakon što je izmiješan.
The medicine should only be given by a healthcare professional.
Lijek smije primjenjivati samo zdravstveni djelatnik.
The medicine was also shown to have an acceptable safety profile.
Utvrđeno je da lijek posjeduje i prihvatljivi sigurnosni profil.
The medicine was compared with placebo (a dummy treatment) in 360 patients, atenolol (a beta-blocker) in 939 patients and amlodipine (another medicine used to treat angina) in 1,195 patients.
Lijek je uspoređen s placebom (prividnim liječenjem) u 360 bolesnika, atenololom (beta blokatorom) u 939 bolesnika i amlodipinom (drugim lijekom koji se koristi za liječenje angine) u 1 195 bolesnika.
The medicine was compared with placebo (a dummy treatment) in 360 patients, atenolol (a beta-blocker) in 939 patients and amlodipine (another medicine used to treat angina) in 1,195 patients.
Lijek je uspoređen s placebom (prividnim liječenjem) u 360 bolesnika, atenololom (beta blokatorom) u 939 bolesnika i amlodipinom (drugim lijekom koji se koristi za liječenje angine) u 1.195 bolesnika.
The medicine was generally well tolerated, although the CHMP noted the possible risk of infrequent but severe hypersensitivity reactions.
Lijek je općenito dobro podnošen, iako je CHMP uočio mogući rizik od neučestalih, no ozbiljnih preosjetljivih reakcija.
The medicine was more effective at weekly doses of 1.5 mg than
Lijek je bio djelotvorniji u tjednim dozama od 1,5 mg nego od
The medicine will be administered continuously from a pump either implanted into your abdominal wall or placed externally in a belt pouch.
Lijek će biti primijenjen kontinuirano iz pumpe koja je ili ugrađena (implantirana) u Vašu trbušnu stijenku ili je nosite izvan tijela, u posebnoj vrećici pričvršćenoj oko struka.
The Medicines Company UK Ltd 115L Milton Park, Abingdon Oxfordshire OX14 4SA UNITED KINGDOM
The Medicines Company UK Ltd 115L Milton Park, Abingdon Oxfordshire OX14 4SA UJEDINJENO KRALJEVSTVO
The medicines in Akynzeo attach to the receptors in the nervous system through which serotonin and substance P work: netupitant (an NK1 receptor antagonist) blocks the receptors for substance P, and palonosetron (a 5- HT3 receptor antagonist) blocks certain receptors for serotonin.
Lijekovi u Akynzeu vežu se na receptore u živčanom sustavu kroz koje djeluju serotonin i tvar P: netupitant (antagonist receptora NK1) blokira receptore za tvar P, a palonozetron (antagonist receptora 5-HT3) blokira određene receptore za serotonin.
The medicines in the following list must not be taken during your course of VFEND treatment:
Lijekovi navedeni u sljedećem popisu ne smiju se uzimati za vrijeme liječenja lijekom VFEND:
The medicines in the following list must not be taken during your Voriconazole Hospira treatment:
Lijekovi navedeni u sljedećem popisu ne smiju se uzimati za vrijeme liječenja lijekom Vorikonazol Hospira:
The medicines listed here may not be the only ones that could interact with Bosulif.
Ovdje navedeni lijekovi možda nisu jedini koji mogu imati uzajamno djelovanje s Bosulifom.
The medicines used for this treatment can damage the lining of the blood vessels in the liver, leading to the formation of clots and obstruction of the vessels seen in VOD.
Lijekovi koji se koriste za ovo liječenje mogu oštetiti unutarnju prevlaku krvnih žila jetre, što može uzrokovati formiranje ugrušaka i opstrukciju krvnih žila što je karakteristično za VOD.
The medicines used in combincation with Lumark could affect your ability to drive and to use machines.
Lijekovi koji se upotrebljavaju u kombinaciji s Lumarkom mogli bi utjecati na vašu sposobnost upravljanja vozilima i strojevima.
The medicines were used as an add- on to ciclosporin and corticosteroids.
Lijekovi su korišteni kao dodatne terapije ciklosporinu i kortikosteroidima.
The medicine’s effectiveness was measured by looking at the number of patients who either had problems related to clotting in the veins or who died of any cause during the treatment period.
Djelotvornost lijeka izmjerena je na temelju broja bolesnika koji su imali probleme povezane s nastankom krvnih ugrušaka u venama ili koji su umrli od bilo kojeg razloga tijekom razdoblja liječenja.
The medicine’s effects were maintained for up to a year in two of the studies.
Djelovanje lijeka održano je tijekom godine dana u dva provedena ispitivanja.
The Mekinist 0.5 mg film-coated tablets are yellow, modified oval, biconvex, with “GS” debossed on one face and “TFC” on the opposing face.
Mekinist 0,5 mg filmom obložene tablete su žute, modificirano ovalne, bikonveksne tablete s utisnutom oznakom ‘GS’ na jednoj i ‘TFC’ na suprotnoj strani.
The Mekinist 2 mg film-coated tablets are pink, round, biconvex, with “GS” debossed on one face and “HMJ” on the opposing face.
Mekinist 2 mg filmom obložene tablete su ružičaste, okrugle, bikonveksne tablete s utisnutom oznakom ‘GS’ na jednoj i ‘HMJ’ na suprotnoj strani.
The melted tablet may be swallowed with or without water.
Rastopljenu tabletu možete progutati s vodom ili bez vode.
The Memantine Merz treatment initiation pack is only to be used for the beginning of the treatment with Memantine Merz.
Pakovanje ovaj lijek za početak liječenja se treba koristiti samo na početku liječenja Memantine Merzom.
The Member States should ensure that all conditions or restrictions with regard to the safe and effective use of the medicinal product described below are implemented:
Zemlje članice trebaju primjenjivati u nastavku opisane uvjete i ograničenja vezane uz sigurnu i učinkovitu primjenu lijeka:
The meta-analysis showed that exposure to CHAMPIX resulted in a hazard ratio for MACE of 2.83 (95% confidence interval from 0.76 to 10.55, p=0.12) for patients during treatment and 1.95 (95% confidence interval from 0.79 to 4.82, p=0.15) for patients up to 30 days after treatment.
Meta-analiza je pokazala da je izloženost lijeku CHAMPIX u bolesnika dovela do omjera rizika za MACE događaje od 2,83 (95% intervala pouzdanosti od 0,76 do 10,55, p=0,12) tijekom liječenja i 1,95 (95% intervala pouzdanosti od 0,79 do 4,82, p=0,15) do 30 dana nakon liječenja.
The metabolic activation pathway involves sequential hydrolysis of the carboxyl ester moiety catalysed by human cathepsin A (CatA) or carboxylesterase 1 (CES1) and phosphoramidate cleavage by histidine triad nucleotide-binding protein 1 (HINT1) followed by phosphorylation by the pyrimidine nucleotide biosysthesis pathway.
Put metaboličke aktivacije uključuje sekvencionalnu hidrolizu karboksilnog estera koju kataliziraju ljudski katepsin A (CatA) ili karboksilesteraza 1 (CES1) i cijepanje fosforamidata histidinskim trijadnim proteinom 1 koji veže nukleotide (engl. histidine triad nucleotide-binding protein 1, HINT1) za kojom slijedi fosforilacija putem biosinteze pirimidinskih nukleotida.
The metabolic activation pathway involves sequential hydrolysis of the carboxyl ester moiety catalysed by human cathepsin A or carboxylesterase 1 and phosphoramidate cleavage by histidine triad nucleotide-binding protein 1 followed by phosphorylation by the pyrimidine nucleotide biosynthesis pathway.
Put metaboličke aktivacije uključuje sekvencionalnu hidrolizu karboksilnog estera koju kataliziraju ljudski katepsin A ili karboksilesteraza 1 i cijepanje fosforamidata histidinskim trijadnim proteinom 1 koji veže nukleotide (engl. histidine triad nucleotide-binding protein 1) za kojom slijedi fosforilacija putem biosinteze pirimidinskih nukleotida.
The metabolic disposition of bazedoxifene in postmenopausal women has been determined following oral administration of 20 mg of radiolabeled bazedoxifene.
Metabolička dispozicija bazedoksifena u postmenopauzalnih žena utvrđena je nakon peroralne primjene 20 mg radioaktivno obilježenog bazedoksifena.
The metabolic disposition of CE and bazedoxifene, after administration of CE/bazedoxifene, has not been studied.
Metabolička dispozicija KE i bazedoksifena nakon primjene KE/bazedoksifena nije ispitivana.
The metabolic pathway responsible for the formation of erythrohydrobupropion is unknown.
Metabolički put odgovoran za stvaranje eritrohidrobupropiona je nepoznat.
The metabolic rate is decreased in patients with severe liver dysfunction resulting in a doubling of the area under the plasma concentration-time curve of esomeprazole.
U bolesnika s teškim oštećenjem jetrene funkcije metabolizam esomeprazola je smanjen, što dovodi do udvostručenja površine ispod krivulje.
The metabolisation of pitolisant in humans is not completely characterized.
Metabolizacija pitolizanta kod ljudi nije potpuno karakterizirana.
The metabolism in horses has not been investigated.
Metabolizam kod konja nije istraživan.
The metabolism in horses was not investigated.
Metabolizam u konja nije ispitan.
The metabolism is qualitatively similar in rats, humans, cattle and pigs (including mini-pigs), although quantitatively there are differences.
Iako kvantitativno postoje razlike, metabolizam je kvalitativno sličan u štakora, malih pasmina svinja, ljudi, goveda i svinja.
The metabolism of aprepitant occurs largely via oxidation at the morpholine ring and its side chains and the resultant metabolites were only weakly active.
Aprepitant se pretežno metaboliziraoksidacijom na morfolinskom prstenu i njegovim postraničnim lancima, a nastali metaboliti su pokazali tek slabu aktivnost.
The metabolism of arsenic trioxide involves oxidation of arsenious acid (AsIII), the active species of arsenic trioxide, to arsenic acid (AsV), as well as oxidative methylation to monomethylarsonic acid (MMAV) and dimethylarsinic acid (DMAV) by methyltransferases, primarily in the liver.
Metabolizam arsenova trioksida uključuje oksidaciju arsenične kiseline (AsIII), aktivnog oblika arsenova trioksida u arsenovu kiselinu (AsV), kao i oksidativnu metilaciju u monometilarsoničnu kiselinu (MMAV) i dimetilarseničnu kiselinu (DMAV) putem metiltransferaza, prvenstveno u jetri.
The metabolism of asparaginase is not known but thought to occur via degradation within the reticulo- histiocytic system and by serum proteases.
Metabolizam asparaginaze nije poznat, ali smatra se da se odvija putem degradacije unutar retikulohistiocitnog sustava te putem serumskih proteaza.
The metabolism of bazedoxifene may be increased by concomitant use of substances known to induce UGTs, such as rifampicin, phenobarbital, carbamazepine, and phenytoin, potentially leading to decreased systemic concentrations of bazedoxifene.
Metabolizam bazedoksifena može se povećati istodobnom primjenom tvari za koje se zna da induciraju UGT enzime, kao što su rifampicin, fenobarbital, karbamazepin i fenitoin, što potencijalno vodi smanjenju sustavne koncentracije bazedoksifena.
The metabolism of dabrafenib is primarily mediated by CYP2C8 and CYP3A4 to form hydroxy- dabrafenib, which is further oxidised via CYP3A4 to form carboxy-dabrafenib.
Metabolizam dabrafeniba je primarno posredovan s CYP2C8 i CYP3A4 kako bi nastao hidroksi- dabrafenib, koji se dalje oksidira putem CYP3A4 i stvara karboksi-dabrafenib.
The metabolism of deslorelin is rapid.
Metabolizam desorelina je brz.
The metabolism of esomeprazole in patients with mild to moderate liver dysfunction may be impaired.
Metabolizam esomeprazola u bolesnika s blagim do umjerenim oštećenjem jetrene funkcije može biti poremećen.
The metabolism of esomeprazole is not significantly changed in elderly patients (71-80 years of age).
Metabolizam esomeprazola nije značajno drugačiji u starijih ispitanika (71-80 godina).
The metabolism of intravenous lidocaine is inhibited by co-administration of propranolol, resulting in a 25% increase in lidocaine concentrations.
Metabolizam intravenskog lidokaina inhibiran je istodobnom primjenom propranolola, što rezultira povećanjem koncentracije lidokaina od 25%.
The metabolism of lidocaine and prilocaine results in the formation of 2,6-xylidine and o-toluidine, respectively, amongst other metabolites.
Među ostalim metabolitima, razgradnja lidokaina i prilokaina dovodi do stvaranja 2,6-ksilidina, odnosno o-toluidina.
The metabolism of olanzapine may be induced by smoking and carbamazepine, which may lead to reduced olanzapine concentrations.
Metabolizam olanzapina može se inducirati pušenjem i karbamazepinom što može dovesti do smanjenja koncentracije olanzapina.
The metabolism of Perjeta has not been directly studied.
Nisu provedena izravna ispitivanja metabolizma lijeka Perjeta.
The metabolism of propranolol is reduced by co-administration of quinidine, leading to a two- three fold increased blood concentration and greater degrees of clinical beta-blockade.
Metabolizam propranolola je smanjen kod istodobne primjene kinidina, što dovodi do dva do tri puta povišene koncentracije u krvi i većih stupnjeva kliničkih beta-blokada.
The metabolism of technetium Tc 99m tilmanocept has not been investigated experimentally.
Metabolizam tilmanocepta obilježenog rdioaktivnim tehnecijem Tc 99m nije eksperimentalno ispitan.
The metabolism of valdecoxib may increase when co-administered with enzyme inducers such as rifampicin, phenytoin, carbamazepine or dexamethasone.
Metabolizam valdekoksiba može biti pojačan kad se istodobno primjenjuju induktori enzima kao što su rifampicin, fenitoin, karbamazepin ili deksametazon.
The metabolite NW-1153 is a substrate for OAT3 at clinically relevant concentrations.
Metabolit NW-1153 je supstrat za OAT3 u klinički relevantnim koncentracijama.
The metabolites and parent are eliminated from the body via urinary and biliary excretion with the majority eliminated in the bile.
Metaboliti i matični spoj se eliminiraju iz tijela putem mokraće te bilijarnim izlučivanjem, s većom eliminacijom putem žuči.
The metabolites are eliminated from plasma and urine in 2 phases, for which half-lives of about 2 and 5 hours (plasma) and 2 and 18 hours (urine) have been calculated.
Metaboliti se iz plazme i urina eliminiraju u 2 faze, za koje su izračunati poluvijeci od približno 2 i 5 sati (plazma), odnosno 2 i 18 sati (urin).
The metabolites of idebenone are coloured and may cause chromaturia, i.e. a reddish-brown discoloration of the urine.
Metaboliti idebenona su obojani i mogu uzrokovati kromaturiju, odnosno obojati urin u crvenkasto- smeđu boju.
The Metalyse solvent is water for injections.
Otapalo lijeka Metalyse je voda za injekcije.
The metering pump is comprised of an outer bottle with a pouch liner, a metering pump and a cap.
Odmjerna pumpica sastoji se od vanjske boce sa zaštitnom vrećicom, odmjerne pumpice i zatvarača.
The metering pump is comprised of an outer polypropylene bottle with a Low Density Polyethylene (LDPE) pouch liner, a polypropylene metering pump, with ethylene propylene diene monomer (EPDM) gaskets, and a polypropylene cap.
Odmjerna pumpica sastoji se od vanjske polipropilenske boce sa zaštitnom vrećicom od polietilena niske gustoće (LDPE), odmjerne pumpice od polipropilena, s brtvama od etilenpropilendien monomera (EPDM), i polipropilenskog zatvarača.
The method of administration and timing of medicine intake
Načinu primjene i planiranju vremena unosa lijeka.
The method of administration is by coarse spray by using a suitable device (volume delivered: 28 ml/100 chicks, droplet size: 200–250 µm and working pressure: 2 to 3 bars).
Način primjene je raspršivanje velikim kapljicama koristeći odgovarajući uređaj (isporučeni volumen: 28 ml/100 pilića, veličina kapi: 200-250 µm i radni tlak: 2 do 3 bara).
The method of administration is by intramuscular route, in the neck muscles.
Način primjene u vratni mišić.
The method of preparation of NexoBrid and of its application to wound area
Način pripreme NexoBrida i njegova primjena na područje rane
The method used to estimate renal function (CrCL in mL/min) during the clinical development of Pradaxa was the Cockcroft-Gault method (see section 4.2 Pradaxa 75 mg).
Metoda koja se koristila za ocjenu bubrežne funkcije (CrCL in mL/min) tijekom kliničkog razvoja Pradaxe bila je Cockcroft-Gaultova metoda (vidjeti dio 4.2 Pradaxa 75 mg).
The method used to estimate renal function (CrCL in mL/min) during the clinical development of Pradaxa was the Cockcroft-Gault method (see section 4.2 Pradaxa 75 mg).
Metoda koja se koristila za procjenu bubrežne funkcije (CrCL in mL/min) tijekom kliničkog razvoja Pradaxe bila je Cockcroft-Gaultova metoda (vidjeti dio 4.2 Pradaxa 75 mg).
The method used to estimate renal function (CrCL in mL/min) during the clinical development of Pradaxa was the Cockcroft-Gault method.
Metoda koja se koristila za procjenu bubrežne funkcije (CrCL po mL/min) tijekom kliničkog razvoja Pradaxe bila je Cockcroft-Gaultova metoda.
The method used to estimate renal function (CrCL in mL/min) during the clinical development of Pradaxa was the Cockcroft-Gault method. (see section 4.2 Pradaxa 75 mg)
Metoda koja se koristila za procjenu bubrežne funkcije (CrCL in mL/min) tijekom kliničkog razvoja Pradaxe bila je Cockcroft-Gaultova metoda (vidjeti dio 4.2 Pradaxa 75 mg).
The methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216) may cause allergic reactions (possibly delayed).
Metil parahidroksibenzoat (E218) i propil parahidroksibenzoat (E216) mogu uzrokovati alergijske reakcije (koje mogu biti zakašnjele).
The MIC and MBC data are reported from a representative sample of isolates from field materials within different EU geographic areas.
MIC i MBC podaci su dobiveni iz reprezentativnih uzoraka izolata, materijala s terena iz različitih geografski područja EZ.
The microbiological data suggest that posaconazole is active against Rhizomucor, Mucor, and Rhizopus, however the clinical data are currently too limited to assess the efficacy of posaconazole against these causative agents.
Mikrobiološki podaci ukazuju da posakonazol djeluje na Rhizomucor, Mucor i Rhizopus, no trenutno nema dovoljno kliničkih podataka za procjenu djelotvornosti posakonazola na te uzročnike.
The microbubble dispersion is prepared before use by injecting through the septum 5 ml of sodium chloride 9 mg/ml (0.9%) solution for injection to the contents of the vial.
Disperzija mikromjehurića pripremi se prije uporabe ubrizgavanjem 5 ml 9 mg/ml (0,9%) otopine natrijevog klorida za injekciju kroz čep u sadržaj bočice.
The midazolam half- life was increased about 2.5-fold.
Poluvijek midazolama povećao se približno 2,5 puta.
the middle size blue spoon measures 150 mg of betaine anhydrous powder ;
rednja plava žličica mjeri 150 mg bezvodnog praška betaina;